Today Dr. Martin Gleave of the Vancouver Prostate Centre in Canada gave a lecture about new approaches to treat castrate-resistant prostate cancer (CRCP) during the 24th Annual Congress of the…

The prostate cancer screening tests that have become an annual ritual for many men don’t appear to reduce deaths from the disease among those with…

In the January 7, 2009 issue of the Journal of the American Medical Association, Dr. Scott Lippman and associates presented the results of…

A multi-center study of prostate cancer patients appearing in today’s Journal of Urology recommends that for some men diagnosed with low-risk prostate cancer, opting…

A study led by researchers at the University of Southern California (USC) found that men who took a daily folic acid supplement of 1 mg daily had…

The so-called “male lumpectomy”—a minimally invasive interventional radiology treatment for prostate cancer—is as effective as surgery in destroying diseased tumors and can be considered a first-line treatment for patients…

In the online edition of Molecular Nutrition and Food Research, Ruth Chan and collaborators provided a review on prostate cancer (CaP) and vegetable…

Among men who have been treated for prostate cancer, those who are particularly anxious after signs of a recurrence may not make the best decision about the next step in…

PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate…

We recently reviewed evidence relating diet and prostate cancer, suggesting that a traditional Cretan Mediterranean style diet based on a variety of plant foods (fruits, vegetables, wholegrain cereals, nuts and…

New research findings out of Wake Forest University School of Medicine and the University of Wisconsin may help provide some direction for men diagnosed with prostate cancer about whether…

For men suffering the discomforts of an enlarged prostate, injections of Botox into the prostate may bring relief for up to 30 months, doctors in Italy report.

Dr. Giuseppe Brisinda of Catholic University…

A test that looks for tumor cells in the blood may make doctors better able to check whether chemotherapy is helping a prostate cancer patient, researchers reported on Tuesday.

The CellSearch…

A new study at the University of Haifa discovered:
Worldwide, countries with the highest levels of artificial light at night also have the highest rates of prostate…

A new study at the University of Haifa discovered:
Worldwide, countries with the highest levels of artificial light at night also have the highest rates of prostate…

Being overweight or obese increases a man’s risk of prostate cancer recurrence after radical surgery for prostate cancer, research shows.

“Obesity is not only a risk factor for known medical conditions,…

DHEA is a natural circulating hormone and the body’s production of it decreases with age. Men take DHEA as an over-the-counter supplement because it has…

The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers…

In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated…

Low-income men are more likely to present with advanced prostate cancers, most likely because they don’t receive screening services shown to reduce the diagnosis of later-stage…

In a major cancer prevention study, long-term supplementation with vitamin E or C did not reduce the risk of prostate or other…

Prostate cancer – and perhaps other cancers – promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from…

Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University.

Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an…